LANTERN: Lymphatic disease Advancements with Nanotechnology, Translational Epigenetics, and Research in Genetics
Weill Cornell Medicine in New York City will develop a comprehensive diagnostic platform that integrates AI-enabled biomarker technologies, high-resolution photoacoustic imaging, and multimodal genetic-epigenetic predictors, giving clinicians the ability to detect lymphatic dysfunction much earlier in the disease process and opening a window for timely intervention before severe symptoms develop.